These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32949352)

  • 1. Developing Medical Affairs Leaders Who Create the Future.
    Bedenkov A; Rajadhyaksha V; Beekman M; Moreno C; Fong PC; Agustin L; Odell S
    Pharmaceut Med; 2020 Oct; 34(5):301-307. PubMed ID: 32949352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.
    Ghosh R; Mohanasundaram S; Shetty S; Menon S
    Pharmaceut Med; 2021 Jul; 35(4):197-202. PubMed ID: 34224113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond.
    Furtner D; Shinde SP; Singh M; Wong CH; Setia S
    Pharmaceut Med; 2022 Feb; 36(1):1-10. PubMed ID: 34970723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building the case for developing a medical affairs patient-centric framework collaboratively.
    Ashkenazy R
    Drug Discov Today; 2020 Mar; 25(3):475-479. PubMed ID: 31786366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Can General Managers Best Leverage Medical Affairs Now and in the Future?
    Zdon J; Chatgilaou GJ; Henderson D; Britland M; Tregenza S; McNeil N; Otto D; Downey J
    Pharmaceut Med; 2024 Jul; 38(4):277-290. PubMed ID: 39003401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring opportunities for collaboration between the corporate sector and the dental education community.
    Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
    Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Yesterday, today and tomorrow: urology and the pharmaceutical industry: successful team work for the benefit of the patient].
    Cardinal A
    Urologe A; 2006 Sep; 45 Suppl 4():43-4. PubMed ID: 16955326
    [No Abstract]   [Full Text] [Related]  

  • 9. [Introductory overview article: internationalization of the health care industry].
    von Bandemer S; Blank W; Büchel D
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):607-15. PubMed ID: 22142884
    [No Abstract]   [Full Text] [Related]  

  • 10. The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group.
    Wu-Pong S; Gobburu J; O'Barr S; Shah K; Huber J; Weiner D;
    Am J Pharm Educ; 2013 May; 77(4):S2. PubMed ID: 23716757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building and Sustaining Effective Partnerships for Training the Next Generation of Global Health Leaders.
    Nakanjako D; Kendall D; Sewankambo NK; Razak MH; Oduor B; Odero T; Garcia P; Farquhar C
    Ann Glob Health; 2021; 87(1):66. PubMed ID: 34307069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U-BIOPRED: evaluation of the value of a public-private partnership to industry.
    Riley JH; Erpenbeck VJ; Matthews JG; Holweg CTJ; Compton C; Seibold W; Higenbottam T; Wagers S; Rowe A; Myles D;
    Drug Discov Today; 2018 Sep; 23(9):1622-1634. PubMed ID: 29936248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Collaboration Challenge: Global Partnerships to Achieve Global Goals.
    Bzdak M
    World Health Popul; 2017; 17(3):81-92. PubMed ID: 29400276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spin cycles. Healthcare marketing-communications efforts have taken on increasing strategic importance.
    Romano M
    Mod Healthc; 2005 Nov; 35(47):28-30. PubMed ID: 16334365
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.
    da Veiga CP; da Veiga CR; Del Corso JM; da Silva WV
    Int J Environ Res Public Health; 2015 Aug; 12(8):9454-74. PubMed ID: 26274968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fostering partnerships: an industry perspective.
    Cagle GD
    Retina; 2005 Dec; 25(8 Suppl):S87. PubMed ID: 16374357
    [No Abstract]   [Full Text] [Related]  

  • 20. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.